Literature DB >> 13666391

Utilization of hypoxanthine, adenine and 4-amino-5-imidazole-carboxamide for uric acid synthesis in man.

J B WYNGAARDEN, J E SEEGMILLER, L LASTER, A E BLAIR.   

Abstract

Entities:  

Keywords:  ADENINE/metabolism; AMIDES; IMIDAZOLES/metabolism; URIC ACID/metabolism; XANTHINES/metabolism

Mesh:

Substances:

Year:  1959        PMID: 13666391

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  8 in total

1.  THE STUDY OF PURINE UTILIZATION AND EXCRETION IN A XANTHINURIC MAN.

Authors:  J H AYVAZIAN; S SKUPP
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

2.  The metabolism of ring-labeled orotic acid in man.

Authors:  S M WEISSMAN; A Z EISEN; H FALLON; M LEWIS; M KARON
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

3.  [Studies on the fate of purines liberated from nucleic acids in cell degradation during epidermal keratinization].

Authors:  E SCHWARZ
Journal:  Arch Klin Exp Dermatol       Date:  1963

4.  Excretion of 4-Amino-5-Imidazolecarboxamide by Various Animal Species.

Authors:  P L McGeer; E G McGeer; A J Wood
Journal:  Can J Comp Med Vet Sci       Date:  1961-08

Review 5.  The study of human intermediary purine metabolism and its regulation.

Authors:  J E Seegmiller
Journal:  Proc R Soc Med       Date:  1966-04

6.  Uric acid production with particular reference to the role of xanthine oxidase and its inhibition.

Authors:  R W Watts
Journal:  Proc R Soc Med       Date:  1966-04

7.  Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.

Authors:  N L Edwards; D Recker; I H Fox
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Suppression of glycine-15N incorporation into urinary uric acid by adenine-8-13C in normal and gouty subjects.

Authors:  J E Seegmiller; J R Klinenberg; J Miller; R W Watts
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.